Skip to main content
Erschienen in:

13.01.2020

Efficacy of per-oral endoscopic myotomy for the treatment of non-achalasia esophageal motor disorders

verfasst von: Lucie Bernardot, Sabine Roman, Maximilien Barret, Véronique Vitton, Timothée Wallenhorst, Mathieu Pioche, Stanislas Chaussade, Jean-Michel Gonzalez, Thierry Ponchon, Frédéric Prat, Marc Barthet, Julien Vergniol, Edouard Chabrun, Frank Zerbib

Erschienen in: Surgical Endoscopy | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Per-oral endoscopic myotomy (POEM) is effective in achalasia. The objective of this study was to evaluate the short-term clinical efficacy of POEM in non-achalasia esophageal motility disorders (NAEMD).

Patients and methods

Patients with NAEMD diagnosed by high-resolution manometry were included in a retrospective multicentric study. For each individual case, two controls paired on gender and age were matched: one with type I/II achalasia and one with type III achalasia. The clinical response, defined by an Eckardt score ≤ 3, was assessed at 3 and 6 months.

Results

Ninety patients (mean age 66 years, 57 men) were included, 30 patients with NAEMD (13 jackhammer esophagus, 6 spastic esophageal disorders, 4 nutcracker esophagus, and 7 esophagogastric junction obstruction), 30 patients with type I–II achalasia, and 30 patients with type III achalasia. The 3-month response rates were 80% (24/30), 90% (27/30), and 100% (30/30) in NAEMD, type I–II achalasia and type III achalasia, respectively (p < 0.01). Eckardt scores improved from preoperative baseline in all groups (median scores 2.0 after POEM vs. 6.5 before POEM, 1.3 vs. 7.2, and 0.5 vs. 6.1 in NAEMD, type I//I and Type III, respectively). No predictive factor of response was identified. In NAEMD patients, there was a significant improvement of dysphagia, regurgitation, and chest pain scores. The 6-month response rates were 63.2% (12/19), 95.5% (21/22), and 87.0% (20/23) in NAEMD, type I–II achalasia and type III achalasia, respectively (p = 0.03).

Conclusion

Although less effective than in achalasia, POEM is an effective treatment for NAEMD. Long-term follow-up data are needed to further confirm that POEM may be a valid treatment of NAEMD.
Literatur
1.
Zurück zum Zitat Kahrilas PJ, Katzka D, Richter JE (2017) Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology 153:1205–1211CrossRefPubMedCentral Kahrilas PJ, Katzka D, Richter JE (2017) Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology 153:1205–1211CrossRefPubMedCentral
2.
Zurück zum Zitat Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S (2010) Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42:265–271CrossRef Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S (2010) Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42:265–271CrossRef
3.
Zurück zum Zitat Haito-Chavez Y, Inoue H, Beard KW, Draganov PV, Ujiki M, Rahden BHA, Desai PN, Pioche M, Hayee B, Haji A, Saxena P, Reavis K, Onimaru M, Balassone V, Nakamura J, Hata Y, Yang D, Pannu D, Abbas A, Perbtani YB, Patel LY, Filser J, Roman S, Rivory J, Mion F, Ponchon T, Perretta S, Wong V, Maselli R, Ngamruengphong S, Chen YI, Bukhari M, Hajiyeva G, Ismail A, Pieratti R, Kumbhari V, Galdos-Cardenas G, Repici A, Khashab MA (2017) Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol 112:1267–1276CrossRef Haito-Chavez Y, Inoue H, Beard KW, Draganov PV, Ujiki M, Rahden BHA, Desai PN, Pioche M, Hayee B, Haji A, Saxena P, Reavis K, Onimaru M, Balassone V, Nakamura J, Hata Y, Yang D, Pannu D, Abbas A, Perbtani YB, Patel LY, Filser J, Roman S, Rivory J, Mion F, Ponchon T, Perretta S, Wong V, Maselli R, Ngamruengphong S, Chen YI, Bukhari M, Hajiyeva G, Ismail A, Pieratti R, Kumbhari V, Galdos-Cardenas G, Repici A, Khashab MA (2017) Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol 112:1267–1276CrossRef
4.
Zurück zum Zitat Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE, International High Resolution Manometry Working G (2015) The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 27:160–174CrossRef Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE, International High Resolution Manometry Working G (2015) The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 27:160–174CrossRef
5.
Zurück zum Zitat Zerbib F, Roman S (2015) Current therapeutic options for esophageal motor disorders as defined by the Chicago classification. J Clin Gastroenterol 49:451–460 Zerbib F, Roman S (2015) Current therapeutic options for esophageal motor disorders as defined by the Chicago classification. J Clin Gastroenterol 49:451–460
6.
Zurück zum Zitat Mion F, Marjoux S, Subtil F, Pioche M, Rivory J, Roman S, Zerbib F (2019) Botulinum toxin for the treatment of hypercontractile esophagus: results of a double-blind randomized sham-controlled study. Neurogastroenterol Motil 31:e13587CrossRef Mion F, Marjoux S, Subtil F, Pioche M, Rivory J, Roman S, Zerbib F (2019) Botulinum toxin for the treatment of hypercontractile esophagus: results of a double-blind randomized sham-controlled study. Neurogastroenterol Motil 31:e13587CrossRef
7.
Zurück zum Zitat Vanuytsel T, Bisschops R, Farre R, Pauwels A, Holvoet L, Arts J, Caenepeel P, De Wulf D, Mimidis K, Rommel N, Tack J (2013) Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 11(1115–1121):e1112 Vanuytsel T, Bisschops R, Farre R, Pauwels A, Holvoet L, Arts J, Caenepeel P, De Wulf D, Mimidis K, Rommel N, Tack J (2013) Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 11(1115–1121):e1112
8.
Zurück zum Zitat Sharata AM, Dunst CM, Pescarus R, Shlomovitz E, Wille AJ, Reavis KM, Swanstrom LL (2015) Peroral endoscopic myotomy (POEM) for esophageal primary motility disorders: analysis of 100 consecutive patients. J Gastrointest Surg 19:161–170CrossRef Sharata AM, Dunst CM, Pescarus R, Shlomovitz E, Wille AJ, Reavis KM, Swanstrom LL (2015) Peroral endoscopic myotomy (POEM) for esophageal primary motility disorders: analysis of 100 consecutive patients. J Gastrointest Surg 19:161–170CrossRef
9.
Zurück zum Zitat Teitelbaum EN, Dunst CM, Reavis KM, Sharata AM, Ward MA, DeMeester SR, Swanstrom LL (2018) Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders. Surg Endosc 32:421–427CrossRef Teitelbaum EN, Dunst CM, Reavis KM, Sharata AM, Ward MA, DeMeester SR, Swanstrom LL (2018) Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders. Surg Endosc 32:421–427CrossRef
10.
Zurück zum Zitat Khashab MA, Familiari P, Draganov PV, Aridi HD, Cho JY, Ujiki M, Rio Tinto R, Louis H, Desai PN, Velanovich V, Albeniz E, Haji A, Marks J, Costamagna G, Deviere J, Perbtani Y, Hedberg M, Estremera F, Martin Del Campo LA, Yang D, Bukhari M, Brewer O, Sanaei O, Fayad L, Agarwal A, Kumbhari V, Chen YI (2018) Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study. Endosc Int Open 6:E1031–e1036CrossRefPubMedCentral Khashab MA, Familiari P, Draganov PV, Aridi HD, Cho JY, Ujiki M, Rio Tinto R, Louis H, Desai PN, Velanovich V, Albeniz E, Haji A, Marks J, Costamagna G, Deviere J, Perbtani Y, Hedberg M, Estremera F, Martin Del Campo LA, Yang D, Bukhari M, Brewer O, Sanaei O, Fayad L, Agarwal A, Kumbhari V, Chen YI (2018) Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study. Endosc Int Open 6:E1031–e1036CrossRefPubMedCentral
11.
Zurück zum Zitat Filicori F, Dunst CM, Sharata A, Abdelmoaty WF, Zihni AM, Reavis KM, Demeester SR, Swanstrom LL (2019) Long-term outcomes following POEM for non-achalasia motility disorders of the esophagus. Surg Endosc 33:1632–1639CrossRef Filicori F, Dunst CM, Sharata A, Abdelmoaty WF, Zihni AM, Reavis KM, Demeester SR, Swanstrom LL (2019) Long-term outcomes following POEM for non-achalasia motility disorders of the esophagus. Surg Endosc 33:1632–1639CrossRef
12.
Zurück zum Zitat Kane ED, Budhraja V, Desilets DJ, Romanelli JR (2019) Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia. Surg Endosc 33:886–894CrossRef Kane ED, Budhraja V, Desilets DJ, Romanelli JR (2019) Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia. Surg Endosc 33:886–894CrossRef
13.
Zurück zum Zitat Kumbhari V, Tieu A, Onimaru M, El Zein M, Teitelbaum E, Gitelis M, Modayil R, Hungness ES, Stravopoulos S, Shiwaku H, Kunda R, Chiu P, Saxena P, Messallam A, Inoue H, Khashab M (2015) Peroral endoscopy myotomy vs laparoscopic Heller myotomy for the treatment of type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open 3:E195–E201CrossRefPubMedCentral Kumbhari V, Tieu A, Onimaru M, El Zein M, Teitelbaum E, Gitelis M, Modayil R, Hungness ES, Stravopoulos S, Shiwaku H, Kunda R, Chiu P, Saxena P, Messallam A, Inoue H, Khashab M (2015) Peroral endoscopy myotomy vs laparoscopic Heller myotomy for the treatment of type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open 3:E195–E201CrossRefPubMedCentral
14.
Zurück zum Zitat Bechara R, Ikeda H, Inoue H (2016) Peroral endoscopic myotomy for Jackhammer esophagus: to cut or not to cut the lower esophageal sphincter. Endosc Int Open 4:E585–588CrossRefPubMedCentral Bechara R, Ikeda H, Inoue H (2016) Peroral endoscopic myotomy for Jackhammer esophagus: to cut or not to cut the lower esophageal sphincter. Endosc Int Open 4:E585–588CrossRefPubMedCentral
Metadaten
Titel
Efficacy of per-oral endoscopic myotomy for the treatment of non-achalasia esophageal motor disorders
verfasst von
Lucie Bernardot
Sabine Roman
Maximilien Barret
Véronique Vitton
Timothée Wallenhorst
Mathieu Pioche
Stanislas Chaussade
Jean-Michel Gonzalez
Thierry Ponchon
Frédéric Prat
Marc Barthet
Julien Vergniol
Edouard Chabrun
Frank Zerbib
Publikationsdatum
13.01.2020
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 12/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07348-y

Neu im Fachgebiet Chirurgie

Lohnt sich die Karotis-Revaskularisation?

Die medikamentöse Therapie für Menschen mit Karotisstenosen hat sich in den vergangenen Dekaden verbessert. Braucht es also noch einen invasiven Eingriff zur Revaskularisation der Halsschlagader bei geringem bis moderatem Risiko für einen ipsilateralen Schlaganfall?

Höhere Dosis von Dexamethason senkt Überlebenschancen

Personen mit Hirnmetastasen, die perioperativ höhere kumulative Dosen von Dexamethason erhalten, haben eine schlechtere Prognose. Um die Ergebnisse zu verbessern, bedarf es strengerer Dosierungsschemata.

Appendektomie erhält Remission bei Colitis ulcerosa

Wird der Wurmfortsatz bei Personen mit Colitis ulcerosa entfernt, ist die Rückfallrate um ein Drittel geringer als unter konservativer Behandlung. Auch die Lebensqualität verbessert sich und der Bedarf an Medikamenten nimmt ab.

Op.-Entscheidung bei Divertikulitis: Lebensqualität zählt!

Soll man Menschen, die schon mehrfach schmerzhafte Divertikulitisepisoden durchgemacht haben, eine Op. anbieten? Ein Team aus Helsinki rät, dies von der Lebensqualität abhängig zu machen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.